Day One: Wednesday, September 18, 2024 - ET (Eastern Time, GMT-05:00)
Day One: Wednesday, September 18, 2024 - ET (Eastern Time, GMT-05:00)
CPE Credits Available: 0.3
- Adam Weisman - Chief Executive Officer and Co-Founder, Auxilius
- Sharon Langan - VP Partnerships and Community, Auxilius
• Deal trends, landscape, and overall market conditions
• Understanding the data and company maturity behind deal trends
• Most common deal types and their construction
CPE Credits Available: 0.9
• The mechanics behind investor relations from selection to partnership
• Fund raising approaches and important elements such as timing, monetary value, and creativity perspective
CPE Credits Available: 0.9
- Ted Myles - Chief Financial Officer & Chief Operating Officer, Scholar Rock
- Lori Macomber - Chief Financial Officer, Legend Biotech
- Michelle Robertson - Chief Financial Officer, Geron
• CSRD/ESG- SEC Climate disclosure rules status after implementation in March
• Changes to segment disclosure requirements (ASU 2023-07)
• Cybersecurity disclosures feedback and observations
• Top trends in SEC comment letters
CPE Credits Available: 0.9
• Managing budget and billing with CROs
• How to filter changes into forecasting
• The complexities of clinical trial accruals
CPE Credits Available: 0.9
- Jennifer Kyle - Founder and CEO, Condor Software
- Dave Lowrance - Chief Financial Officer, Savara Pharmaceuticals
- Mallory Morales - Chief Accounting Officer, Immuneering
• Managing financial risk during commercial launch phase
• Collaborating with the rest of the business in advance of a launch
• Monitoring performance and adjusting financial plans accordingly
• Managing other priorities unrelated to launch
CPE Credits Available: 0.9
- Joe Goldberg - Partner, RSM US LLP
- Katie Falzone - VP, Corporate Controller, Invivyd
• Software and platforms that grow with the business
• Technology that lends itself to convenient integration
• Opportunities to connect platforms through different departments
CPE Credits Available: 0.9
- Meera Phaltankar - Director of Revenue Accounting, Ironshore Pharmaceuticals, Inc.
- Michael Thater - Corporate Controller, Entrada Therapeutics
- Kyle Breidenstine - Vice President, Finance & Controller, PepGen
I) Hiring Practices
a. Stages of the biotech company journey in connection to growing finance and accounting teams
II) Treasury Management
III) Building strong valuation models for M&A
CPE Credits Available: 1.4
- Patrick Tracey - Executive Director, Finance and Accounting, Elevate Bio
I. Regulatory
a. IFRS
b. Implementing SEC disclosure reporting changes for 2024
II. Public vs. Private Reporting
III. Budget Cycle
a. Forecasting & Planning
CPE Credits Available: 1.4
- Erin Warner Gill - President and Chief Operating Officer, Auxilius
- Christy Fulmer - CPA, Director, Technical Accounting Success, Auxilius
Close process efficiencies
- Challenges within the close process
- Technical implementations to assist in the close process
- Creative solutions for improvement
Financial Reporting
- Internal reporting preparation and key areas for stakeholders
Indirect Taxes
- Operational efficiency / Health Check
- Use of Technology to find overpayment / underpayments
CPE Credits Available: 0.9
- Gina Tracey - Senior Director, Accounting, Alnylam
- T.J. Washburn - Vice President, Controller, Agios Pharmaceuticals
- Jana Kelly - Partner, Crowe LLP
- Christopher Engels - Partner, Crowe LLP